These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16571703)

  • 1. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.
    Wood E; Tyndall MW; Qui Z; Zhang R; Montaner JS; Kerr T
    Am J Public Health; 2006 May; 96(5):770-3. PubMed ID: 16571703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for evaluating North America's first medically supervised safer-injecting facility.
    Wood E; Kerr T; Montaner JS; Strathdee SA; Wodak A; Hankins CA; Schechter MT; Tyndall MW
    Lancet Infect Dis; 2004 May; 4(5):301-6. PubMed ID: 15120347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do supervised injecting facilities attract higher-risk injection drug users?
    Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
    Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.
    Kerr T; Wood E; Small D; Palepu A; Tyndall MW
    CMAJ; 2003 Oct; 169(8):759-63. PubMed ID: 14557313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility.
    Kerr T; Tyndall MW; Zhang R; Lai C; Montaner JS; Wood E
    Am J Public Health; 2007 Jul; 97(7):1228-30. PubMed ID: 17538061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
    Wood E; Tyndall MW; Montaner JS; Kerr T
    CMAJ; 2006 Nov; 175(11):1399-404. PubMed ID: 17116909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
    Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
    Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
    Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
    Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.
    Wood E; Kerr T; Small W; Li K; Marsh DC; Montaner JS; Tyndall MW
    CMAJ; 2004 Sep; 171(7):731-4. PubMed ID: 15451834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
    Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
    Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?
    Wood E; Tyndall MW; Spittal PM; Li K; Kerr T; Hogg RS; Montaner JS; O'Shaughnessy MV; Schechter MT
    CMAJ; 2001 Aug; 165(4):405-10. PubMed ID: 11531048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.
    Reddon H; Wood E; Tyndall M; Lai C; Hogg R; Montaner J; Kerr T
    AIDS Educ Prev; 2011 Oct; 23(5):412-22. PubMed ID: 22010805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a medically supervised injection facility among street youth.
    Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
    J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.
    Wood E; Kerr T; Spittal PM; Li K; Small W; Tyndall MW; Hogg RS; O'Shaughnessy MV; Schechter MT
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):2-8. PubMed ID: 12514408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safer injection facility use and syringe sharing in injection drug users.
    Kerr T; Tyndall M; Li K; Montaner J; Wood E
    Lancet; 2005 Jul 23-29; 366(9482):316-8. PubMed ID: 16039335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
    Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
    BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.
    Wood E; Kerr T; Stoltz J; Qui Z; Zhang R; Montaner JS; Tyndall MW
    Public Health; 2005 Dec; 119(12):1111-5. PubMed ID: 16214189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.